Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Summary by Business Observer
Silo Pharma plans to use the funds for working capital and general corporate purposes.

2 Articles

The Manila TimesThe Manila Times
Lean Right

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

·Manila, Philippines
Read Full Article
Business ObserverBusiness Observer

Sarasota biopharmaceutical company raises $2.5M with stock offering

Silo Pharma plans to use the funds for working capital and general corporate purposes.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Manila Times broke the news in Manila, Philippines on Thursday, October 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Manila icon

Manila

Sarasota icon

Sarasota

News
For You
SearchBlindspotLocal